导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 20.18% | 61/114 |
| 近一周 | -1.16% | 47/129 |
| 近一月 | -3.63% | 48/129 |
| 近一季 | -6.69% | 33/127 |
| 近半年 | 2.65% | 79/120 |
| 近一年 | 22.00% | 50/114 |
| 近两年 | 58.51% | 13/87 |
| 近三年 | 39.20% | 10/66 |
| 成立以来 | 12.92% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
15.99% 93/341 |
1.73% 222/349 |
10.08% 151/355 |
- - |
| 2024 | 29.26% 20/330 |
0.54% 161/280 |
9.61% 23/310 |
18.00% 100/319 |
-0.59% 150/330 |
| 2023 | -10.66% 160/276 |
1.41% 122/205 |
-2.13% 137/230 |
-5.50% 164/262 |
-4.74% 225/276 |
| 2022 | -9.17% 40/202 |
-8.94% 72/153 |
8.06% 43/164 |
-16.46% 107/189 |
10.51% 100/202 |
| 2021 | -22.94% 89/151 |
2.44% 118/312 |
-3.34% 288/328 |
-16.34% 279/358 |
-6.98% 94/151 |
| 2020 | -7.99% 68/104 |
-12.15% 147/280 |
2.95% 265/295 |
-6.07% 269/299 |
8.30% 147/305 |
| 2019 | 13.26% 59/89 |
8.52% 149/258 |
-0.15% 179/268 |
-2.91% 194/253 |
7.66% 106/266 |
| 2018 | -5.57% 31/80 |
- - |
- - |
- - |
-7.99% 95/241 |
| 2017 | 16.90% 35/69 |
- - |
- - |
- - |
- - |
| 2016 | 4.55% 29/59 |
- - |
- - |
- - |
- - |
| 2015 | -14.48% 34/49 |
- - |
- - |
- - |
- - |
| 2014 | 12.66% 19/99 |
- - |
- - |
- - |
- - |
| 2013 | -6.85% 58/70 |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 嘉实标普生物科技精选行业ETF(QDII) | 1.2715 | 28.77% |
| 易方达标普生物科技人民币A | 1.7172 | 27.30% |
| 易方达标普生物科技人民币C | 1.6936 | 27.21% |
| 易方达标普生物科技美元汇A | 0.2432 | 27.07% |
| 汇添富纳斯达克生物科技ETF(QDII) | 1.4590 | 18.72% |
| 广发生物科技指数美元(QDII)A | 0.2081 | 18.51% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)美元现钞 | 1.3424 | 17.84% |
| 广发生物科技指数人民币(QDII)C | 1.4450 | 17.77% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)人民币C | 1.3639 | 17.05% |
| 广发全球医疗保健美元现汇(QDII)A | 0.3574 | 10.55% |
| 易方达恒生国企ETF联接A VS. 天弘恒生科技指数(QDII)C(012349) |